Dynavax Technologies Corp
DVAXDelisted Feb 10, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029142
Dynavax Technologies Corp was delisted on Feb 10, 2026; its insiders filed their last Form 4 on Feb 11, 2026; 267 institutions reported holding it in 13F filings for Q4 2025, worth $1.73B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Dynavax Technologies Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 215
- 0 vs. Q1 2023
- Shares held
- 127.1M
- −712.8K (−0.6%) vs. Q1 2023
- Total value
- $1.64B
- +$387.7M (+30.9%) vs. Q1 2023
- New holders
- 25
- 81 more added
- Sold out
- 25
- 76 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DVAX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $93 |
| Q4 2025 | 267 | $1.73B |
| Q3 2025 | 270 | $1.13B |
| Q2 2025 | 269 | $1.14B |
| Q1 2025 | 283 | $1.65B |
| Q4 2024 | 256 | $1.67B |
| Q3 2024 | 251 | $1.44B |
| Q2 2024 | 238 | $1.48B |
| Q1 2024 | 244 | $1.65B |
| Q4 2023 | 246 | $1.76B |
| Q3 2023 | 226 | $1.86B |
| Q2 2023 | 215 | $1.64B |
| Q1 2023 | 216 | $1.26B |
| Q4 2022 | 230 | $1.25B |
| Q3 2022 | 236 | $1.21B |
| Q2 2022 | 209 | $1.48B |
| Q1 2022 | 206 | $1.10B |
| Q4 2021 | 200 | $1.36B |
| Q3 2021 | 184 | $1.86B |
| Q2 2021 | 154 | $884.7M |
| Q1 2021 | 162 | $823.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Dynavax Technologies Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2,080,193 | $26.9M | 0.00% | −25,117−1.2% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 2,415,000 | $31.2M | 3.21% | −1,500,000−38.3% | Reduced |
| Citadel Advisors LLC | 2,452,144 | $31.7M | 0.04% | +2,356,237+2,456.8% | Added |
| Blair William & Co | 2,455,132 | $31.7M | 0.12% | −74,687−3.0% | Reduced |
| Geode Capital Management, LLC | 2,517,400 | $32.5M | 0.00% | +203,425+8.8% | Added |
| PFM Health Sciences, LP | 2,704,917 | $34.9M | 1.41% | −1,100,453−28.9% | Reduced |
| Dimensional Fund Advisors LP | 3,539,385 | $45.7M | 0.01% | +607,658+20.7% | Added |
| Goldman Sachs Group Inc | 3,592,267 | $46.4M | 0.01% | −105,985−2.9% | Reduced |
| Fisher Asset Management, LLC | 3,900,949 | $50.4M | 0.03% | +14,424+0.4% | Added |
| Chicago Capital, LLC | 5,810,468 | $75.1M | 3.38% | −34,780−0.6% | Reduced |
| Deep Track Capital, LP | 6,557,816 | $84.7M | 3.96% | +207,816+3.3% | Added |
| State Street Corp | 7,788,367 | $100.6M | 0.01% | −1,155,281−12.9% | Reduced |
| Vanguard Group Inc | 8,876,161 | $114.7M | 0.00% | +425,263+5.0% | Added |
| Federated Hermes, Inc. | 12,655,363 | $163.5M | 0.41% | 00.0% | Unchanged |
| BlackRock Inc. | 19,183,847 | $247.9M | 0.01% | +307,793+1.6% | Added |
| Mizuho Markets Cayman LP | 0 | $0 | 0.00% | −756,907−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −416,519−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −205,344−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −165,643−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −79,815−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −76,618−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −75,585−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −72,403−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −46,203−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −39,472−100.0% | Sold out |
| CM Wealth Advisors LLC | 0 | $0 | 0.00% | −36,503−100.0% | Sold out |
| Wealth Effects LLC | 0 | $0 | 0.00% | −27,250−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −23,842−100.0% | Sold out |
| Gallacher Capital Management LLC | 0 | $0 | 0.00% | −20,464−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,450−100.0% | Sold out |
| Banco Bilbao Vizcaya Argentaria, S.A. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −12,830−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −12,320−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −11,125−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −5,282−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −2,499−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −384−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −328−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| ETF Managers Group, LLC | – | – | – | – | Not filed |